PROF (Profound Medical Corporation) Prakiraan pendapatan perusahaan
Profound Medical Corp. (PROF) generates a stable cash flow through the sale of TULSA-PRO systems and consumables. The company's projected sales levels demonstrate its adaptation to market shocks, with the 0.02 value serving as the baseline performance indicator. Growth is driven by the organic adoption of technologies in urology centers, while the high precision of the therapy reduces clinic costs and supports ESG principles.
Rincian analitis lan laporan data perusahaan Profound Medical Corporation (PROF)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Profound Medical Corp.|PROF - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Profound Medical Corp.|PROF - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Profound Medical Corp|PROF - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Profound Medical|Indikator likuiditas cepet profoundmedical.com
- statistik bathi lan rasio pasar:
PROF - Bathi pungkasan|Proyeksi bathi mangsa ngarep Profound Medical Corp.|PROF - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Profound Medical Corp.|PROF - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Profound Medical Corp|PROF - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Profound Medical|PROF - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan profoundmedical.com|PROF - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Profound Medical Corp.
- data dodolan lan asil:
Analisis fundamental perusahaan:Profound Medical
The implementation of Profound Medical Corp. (PROF) unique ultrasound systems into clinical practice directly determines the dynamics of future product sales revenues. This metric analyzes the business's ability to convert operational processes into cash flow, identifying the potential for market share expansion or the risks of an overly conservative strategy. Assessing the company's projected sales volume allows investors to forecast the scaling pace of this high-tech business and the fundamental cost of capital.
Analisis perusahaan pesaing
Volume dodolan mangsa ngarep perusahaan DXCM (DexCom, Inc.)|PEN (penumbrainc.com) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Novanta NOVT|HAE - Volume dodolan mangsa ngarep perusahaan|Inspire Sleep - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Procept|CNMD: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PLSE|INMD (InMode) - Prakiraan volume dodolan|Picard Medical Corp (PMI) - Dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan SRDX|Volume dodolan mangsa ngarep perusahaan Eversense SENS|Prakiraan volume dodolan NPCE (NeuroPace, Inc.)|Prakiraan volume dodolan Tactile Systems Technology, Inc. TCMD|SNWV - Prakiraan pendapatan perusahaan|OM: Prakiraan pendapatan perusahaan|ELMD (smartvest.com) - Volume dodolan mangsa ngarep perusahaan|LENSAR Inc - Pendapatan mangsa ngarep perusahaan|RCEL (AVITA Medical, Inc.) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Baird Medical Corp BDMD|Prakiraan pendapatan perusahaan EDAP TMS S.A. (EDAP)|apyxmedical.com (APYX) - Prakiraan dodolan perusahaan|IceCure Medical - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Pulmonx Corp LUNG|TELA Bio Corp - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Cytosorbents CTSO|Sensus Healthcare (SRTS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan ZYXI (Zynex Medical)|Prakiraan pendapatan perusahaan electroCore Inc|Volume dodolan mangsa ngarep perusahaan Vicarious Surgical Corp (RBOT)|Prakiraan volume dodolan IINN|ICU - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan IRIDEX IRIX|INBS: Prakiraan pendapatan perusahaan|XAIR: Volume dodolan mangsa ngarep perusahaan|Profusa, Inc - Prakiraan volume pendapatan perusahaan|strataskinsciences.com (SSKN) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan GCTK (GlucoTrack Inc.)|Prakiraan pendapatan perusahaan NanoVibronix, Inc.|VERO: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan CHF Solutions (NUWE)|AEMD - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan ASXC (Asensus Surgical)|AVGR (avinger.com) - Pendapatan sing dikarepake perusahaan|BSGM - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Cutera Inc.|KNW (Know Labs Corp) - Volume dodolan mangsa ngarep perusahaan|Inari Medical Corp (NARI) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Nevro Corp.|Prakiraan pendapatan perusahaan RSLS (ReShape Lifesciences Inc)|Prakiraan volume dodolan SILK
